Philips Respironics Recall 2021 {June 2021} Read & Know!

Philips Respironics Recall 2021 Reviews

Philips Respironics Recall 2021 {June 2021} Read & Know! >> This article describes the defective key facts of several ventilators and CPAP breathing machines used for COVID-19 patients and sleep apnea patients.

Is anyone in your community using Philips Ventilator? Then you must follow this article to know all key facts of the machine.

Philips Respironics, a global healthcare firm, is known as a leader in the Sleep and Respiratory market, which believe in three healthier terms as healthier patients lead to healthier practices, and after that produces healthier businesses.

Most of the people in the United States and Canada have obstructive sleep apnea, and for these people, Philips Respironics tries to provide the best solutions, and Philips Respironics Recall 2021 is one of their approaches.

About Philips Respironics

Philips Respironics offers various innovative and unique products for treating sleep and respiratory diseases at home or in hospital. This also contributes to the medical education field and value-added programs to maximize business success and help you easily navigate in a fast-changing industrial field.

As we all are aware about Corona, a pandemic respiratory disease which hits almost every country at a fast rate. In this situation, the requirement for respiratory tools increases day by day.

Philips Respironics Recall 2021

On 14th June, Phillips, a Dutch medical devices company has recalled their 3-4 million ventilators like E30 Ventilator, the Trilogy 100, and 200 ventilators and sleep apnea machines because of some problem seen in machines – degrading of foam particles take place which leads to the release of harmful gases. These gases can easily inhale by users, which can cause health-threatening disease like cancer.

Beneficial Key Facts:

  • Company identifies sound diminishing foam element
  • Inhaling of degraded foam component can cause cancer
  • Advices Restricted usage of CPAP machine by sleep apnea patients
  • Company will mitigate the issue by replacing the foam.
  • Philips Respironics Recall 2021 is for the United States. It is simply a safety notice for other countries.

Health Risks and Repair Program

Philips Respironics provides advice to patients using CPAP machines to stop using it but for COVID-19 patients, since using a ventilator is only the option for their life-sustaining, therefore advise them not to stop this discontinuing it is riskier than the issue found in the recall.

The potential health risks caused by this foam include headache, toxic effects, irritation, respiration choke and also can cause cancer.

In Philips Respironics Recall 2021, the company says it will replace the toxic foam with new material. The whole diagnostic and repairing will probably be ready in a year’s time, cost going up to 500 million euros. Therefore, Philips’ increase the production of the next-generation DreamStation 2 CPAP Platform free from this issue.


The above research reveals that Philips Respironics is the medical company dealing in sleep and respiratory disease equipment. On 14th June, under Philips Respironics Recall 2021, they announced recalling 3-4 million ventilators and CPAP machines due to the risk of degrading a foam part that can cause cancer. However, they plan to mitigate the problem, which can take a year and cost up to 500 million euros. You can check complete detail here

Also Read : Enob Stock Forecast (June 2021) Get Detailed Insight!

Related posts

Why Does a Platform Need to Be Customizable? (Feb) See

Why Does a Platform Need to Be Customizable? (Feb) See -> Are you a business school student? We…
Read more

Why Is Texas Governor in a Wheelchair (Feb) Disability?

Why Is Texas Governor in a Wheelchair (Feb) Disability? -> The story behind the wheelchair would…
Read more

Yak Paint Roller Cleaner (Feb) Know More In Detail

Yak Paint Roller Cleaner (Feb) Know More In Detail -> Have you used any product that would help…
Read more

Leave a Reply

Your email address will not be published. Required fields are marked *